These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30726791)

  • 21. Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort.
    Konta T; Ikeda A; Ichikawa K; Fujimoto S; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Yoshida H; Asahi K; Kurahashi I; Ohashi Y; Watanabe T
    Am J Hypertens; 2012 Mar; 25(3):342-7. PubMed ID: 22089103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta.
    Ross LA; Bloodworth LS; Brown MA; Malinowski SS; Crane R; Sutton V; Karimi M; Dove Brown AC; Dobbs T; Hites L
    Prev Chronic Dis; 2020 Sep; 17():E108. PubMed ID: 32945767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
    Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardio-ankle vascular index value in dyslipidemia patients affected by cardiovascular risk factors.
    Zhao X; Bo L; Zhao H; Li L; Zhou Y; Wang H
    Clin Exp Hypertens; 2018; 40(4):312-317. PubMed ID: 29048932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.
    Zhang FL; Xing YQ; Wu YH; Liu HY; Luo Y; Sun MS; Guo ZN; Yang Y
    Lipids Health Dis; 2017 Mar; 16(1):61. PubMed ID: 28330492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
    Suadicani P; Hein HO; Gyntelberg F
    Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure and lipid target adherence in Korean patients receiving angiotensin II receptor blockers/statin regimens.
    Kim HJ; Kim E; Min KB; Min JY
    Curr Med Res Opin; 2017 Feb; 33(2):385-390. PubMed ID: 27819152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan.
    Wake M; Oh A; Onishi Y; Guelfucci F; Shimasaki Y; Teramoto T
    Atherosclerosis; 2019 Mar; 282():19-28. PubMed ID: 30669019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of cardiovascular events in Italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments.
    Corrao G; Zambon A; Parodi A; Merlino L; Mancia G
    Am J Hypertens; 2012 May; 25(5):549-55. PubMed ID: 22278212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
    Rodrigues CJ; Ribeiro HF; Ribeiro AB; Zanella MT; Batista MC
    Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.
    Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obstructive sleep apnea combined dyslipidemia render additive effect on increasing atherosclerotic cardiovascular diseases prevalence.
    Cao Z; Zhang P; He Z; Yang J; Liang C; Ren Y; Wu Z
    Lipids Health Dis; 2016 May; 15():98. PubMed ID: 27228976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of the EvalObs
    Girerd X; Hanon O; Vaïsse B
    Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):186-190. PubMed ID: 29786508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a combined approach to the management of hypertension and dyslipidemia.
    Ansell BJ
    Am J Hypertens; 2005 Sep; 18(9 Pt 1):1249-57. PubMed ID: 16245413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceptions of Canadian Vascular Surgeons Toward Pharmacologic Risk Reduction in Patients with Peripheral Artery Disease: 2018 Update.
    Li B; Salata K; de Mestral C; Hussain MA; Aljabri BA; Lindsay TF; Verma S; Al-Omran M
    Ann Vasc Surg; 2019 Jul; 58():166-173.e4. PubMed ID: 30771465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities.
    Ishida T; Oh A; Hiroi S; Shimasaki Y; Tsuchihashi T
    Clin Exp Hypertens; 2019; 41(3):203-210. PubMed ID: 29781721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dementia risk by combinations of metabolic diseases and body mass index: Japan Gerontological Evaluation Study Cohort Study.
    Yokomichi H; Kondo K; Nagamine Y; Yamagata Z; Kondo N
    J Diabetes Investig; 2020 Jan; 11(1):206-215. PubMed ID: 31207179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE study.
    Alexopoulos D; Anastasiou-Nana M; Elisaf MS; Liberopoulos E; Rallidis LS; Davos CH; Moulis A; Nikas N; Zacharis E; Vardas P;
    Int J Cardiol; 2016 Aug; 217():183-9. PubMed ID: 27183455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between baseline LDL-cholesterol and cardiovascular outcomes in high cardiovascular risk hypertensive patients: A post-hoc SPRINT data analysis.
    Nguyen LS; Procopi N; Salem JE; Squara P; Funck-Brentano C
    Int J Cardiol; 2019 Jul; 286():159-161. PubMed ID: 30685099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.